miR-31 functions as an oncogene in cervical cancer

MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2

(2014) Junying Chen et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A

(2014) Nan Wang et al.   GYNECOLOGIC ONCOLOGY

Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer

(2014) Osama E Rahma et al.   Journal of Translational Medicine

MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor Cells

(2014) Aoxue Wang et al.   PLoS One

Aberrant Expression of miR-20a and miR-203 in Cervical Cancer

(2013) Shan Zhao et al.   Asian Pacific Journal of Cancer Prevention

A pri-miR-218variant and risk of cervical carcinoma in Chinese women

(2013) Ting-Yan Shi et al.   BMC CANCER

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer

(2013) S. Wang et al.   Clinical & Translational Oncology

MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)

(2013) Cindy Körner et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Interferon-β Induced microRNA-129-5p Down-Regulates HPV-18 E6 and E7 Viral Gene Expression by Targeting SP1 in Cervical Cancer Cells

(2013) Jiarong Zhang et al.   PLoS One

Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm

(2012) Tak-hong Cheung et al.   CELL CYCLE

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

(2012) S M Wilting et al.   ONCOGENE

MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20

(2011) Tingting Yao et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma

(2011) Tengfei Zhang et al.   CLINICAL SCIENCE

Aberrant microRNA expression in human cervical carcinomas

(2011) Qunxian Rao et al.   MEDICAL ONCOLOGY

Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway

(2011) C L Au Yeung et al.   ONCOGENE

A MicroRNA Expression Signature for Cervical Cancer Prognosis

(2010) X. Hu et al.   CANCER RESEARCH

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts

(2010) Olga Aprelikova et al.   CELL CYCLE

MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells

(2010) Jing-Hua Li et al.   GYNECOLOGIC ONCOLOGY

Reduced miR-34a Expression in Normal Cervical Tissues and Cervical Lesions With High-Risk Human Papillomavirus Infection

(2010) Baohua Li et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells

(2010) Charisa L. Cottonham et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

(2010) Xi Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins

(2010) M. Melar-New et al.   JOURNAL OF VIROLOGY

miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer

(2009) Nora Bandi et al.   CANCER RESEARCH

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

(2008) Désirée Bonci et al.   NATURE MEDICINE

Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth

(2008) Xiaohong Wang et al.   PLoS One